Balancing Cost and Care With GLP-1 Employee Benefits | Honest HR
Why It Matters
Decisions about GLP-1 coverage will materially affect benefit costs, workforce health and productivity; choosing flexible PBM arrangements and integrating behavioral supports can help employers balance employee demand with financial sustainability.
Summary
GLP-1 medications have shifted from a clinical development into a major HR and benefits challenge as their effectiveness for obesity, expanding indications, celebrity and social-media attention, and high prevalence of obesity in the workforce fuel demand. Employers are wrestling with whether to extend coverage beyond diabetes to weight-loss indications, a move that raises questions of cost, access and long-term value. Experts urge HR leaders to prioritize their pharmacy benefit manager (PBM) partnership and to design programs that combine drug coverage with lifestyle interventions, mirroring clinical trials that produced durable results. Less than a quarter of employers offered GLP-1 coverage for weight loss as of 2025, underscoring the early but fast-evolving nature of the market.
Comments
Want to join the conversation?
Loading comments...